Regen BioPharma Inc (RGBP)
0.6100
-0.05
(-7.58%)
USD |
OTCM |
May 06, 15:36
Regen BioPharma Cash from Operations (Quarterly): -0.2093M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.2093M |
| December 31, 2023 | -0.1623M |
| September 30, 2023 | -0.0234M |
| June 30, 2023 | -0.087M |
| March 31, 2023 | -0.053M |
| December 31, 2022 | -0.0105M |
| September 30, 2022 | -0.0853M |
| June 30, 2022 | -0.1237M |
| March 31, 2022 | -0.1188M |
| December 31, 2021 | -0.2791M |
| September 30, 2021 | -1.067M |
| June 30, 2021 | -0.0639M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.0057M |
| December 31, 2019 | 0.0243M |
| September 30, 2019 | -0.137M |
| June 30, 2019 | -0.0673M |
| March 31, 2019 | -0.1275M |
| Date | Value |
|---|---|
| December 31, 2018 | -0.15M |
| September 30, 2018 | -0.4656M |
| June 30, 2018 | -0.0814M |
| March 31, 2018 | -0.4035M |
| December 31, 2017 | -0.6273M |
| September 30, 2017 | -0.623M |
| June 30, 2017 | -0.4172M |
| March 31, 2017 | -0.3499M |
| December 31, 2016 | -0.5043M |
| September 30, 2016 | -0.3985M |
| June 30, 2016 | -0.4109M |
| March 31, 2016 | -0.4375M |
| December 31, 2015 | -0.4254M |
| September 30, 2015 | -0.339M |
| June 30, 2015 | -0.3884M |
| March 31, 2015 | -0.2682M |
| December 31, 2014 | -0.1971M |
| September 30, 2014 | -0.1904M |
| June 30, 2014 | -0.1684M |
| March 31, 2014 | -0.195M |
| December 31, 2013 | -0.1931M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.067M
Minimum
Sep 2021
0.0243M
Maximum
Dec 2019
-0.1235M
Average
-0.0656M
Median
Cash from Operations (Quarterly) Benchmarks
| CervoMed Inc | -2.538M |
| GlucoTrack Inc | -2.411M |
| AIM ImmunoTech Inc | -9.758M |
| Protalix BioTherapeutics Inc | 3.595M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.1629M |
| Free Cash Flow | -0.4821M |
| Free Cash Flow Per Share (Quarterly) | -0.0531 |
| Free Cash Flow to Equity (Quarterly) | -0.189M |
| Free Cash Flow Yield | -21.14% |